Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Multi-Dose vs Single-Dose Quadrivalent Influenza Vaccine in Children
NCT03391193Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Vaxigrip in influenza, sponsored by Sanofi. Started Dec 2017; status: completed.
02
Drugs
Vaxigrip
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03391193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03391193.